Investment Rating - The report maintains a "Buy" rating for Meituan-W (3690) with a target price raised to HKD 220, reflecting strong performance and growth potential in core local commerce [2][26]. Core Insights - Meituan's Q3 2024 performance significantly exceeded market expectations, with revenue reaching RMB 936 billion, a year-on-year increase of 22.4%, and operating profit of RMB 137 billion, resulting in an operating profit margin of 14.6% [5][26]. - The core local commerce segment continues to show profitability improvements, with revenue of RMB 694 billion in Q3 2024, up 20.2% year-on-year, and an operating profit margin increase to 21.0% [9][26]. - New business initiatives are showing signs of reduced losses, with new business revenue of RMB 242 billion in Q3 2024, up 28.9% year-on-year, and operating losses narrowing to RMB 10 billion [15][26]. Summary by Sections Financial Performance - Q3 2024 revenue reached RMB 936 billion, surpassing the expected RMB 917 billion, with adjusted net profit of RMB 128 billion, exceeding Bloomberg's consensus of RMB 117 billion [5][26]. - The adjusted EBITDA and adjusted net profit for Q3 2024 grew by 134.8% and 124.0% year-on-year, reaching RMB 145 billion and RMB 128 billion respectively [5][26]. Core Local Commerce - The core local commerce revenue for Q3 2024 was RMB 694 billion, with a year-on-year growth of 20.2% and a quarter-on-quarter increase of 14.3% [9][26]. - Instant delivery transactions reached 7.078 billion orders, with daily average orders at 78.64 million, reflecting a 14.5% year-on-year increase [9][26]. New Business Initiatives - New business revenue for Q3 2024 was RMB 242 billion, with a year-on-year increase of 28.9% and a quarter-on-quarter increase of 12.2% [15][26]. - The company launched its food delivery platform Keeta in Riyadh, Saudi Arabia, as part of its ongoing international expansion efforts [15][26]. Market Position and Outlook - Meituan's competitive position in the local life services market remains strong, with expectations for continued growth in both food delivery and local services despite short-term macroeconomic challenges [26][12]. - The report anticipates that Meituan's business will continue to release operational profits, supported by improved governance and management focus on shareholder returns [26][12].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 5.33, representing a potential upside of 29.06% from the current price of HKD 4.10 [4][3]. Core Insights - The company achieved a revenue of RMB 8.8 billion for the first half of the 2024/2025 fiscal year, reflecting a year-on-year increase of 17.8%, primarily driven by strong growth in branded down jackets and OEM processing management [3]. - The gross profit margin slightly decreased by 0.1 percentage points to 49.9%, influenced by changes in product and brand mix as well as rising down costs [3]. - Operating profit increased by 19.6% to RMB 1.47 billion, benefiting from improved operational efficiency, with a notable 28.3% growth in operating profit excluding the women's wear segment [3]. - The net profit attributable to shareholders reached RMB 1.13 billion, up 23% year-on-year, with a net profit margin improvement of 0.5 percentage points to 12.8% [3]. - The company plans to distribute an interim dividend of HKD 0.06 per share, with a payout ratio of 57.9% [3]. Summary by Sections Financial Performance - Revenue for the first half of 2024/2025 was RMB 8.8 billion, up 17.8% year-on-year, with a gross profit margin of 49.9% [3]. - The operating profit margin improved to 14.7% with a total operating profit of RMB 1.47 billion [3]. - The net profit attributable to shareholders was RMB 1.13 billion, reflecting a 23% increase year-on-year [3]. Business Segments - Branded down jackets generated RMB 6.06 billion in revenue, a 22.7% increase, accounting for 68.9% of total revenue [3]. - OEM processing business revenue was RMB 2.32 billion, up 13.4%, representing 26.3% of total revenue [3]. - Women's wear segment revenue decreased by 21.5% to RMB 310 million, accounting for 3.5% of total revenue [3]. - Diversified apparel revenue increased by 21.3% to RMB 120 million, representing 1.3% of total revenue [3]. Market Outlook - The company aims to achieve revenue exceeding RMB 30 billion for the fiscal year 2025/2026, maintaining confidence in its growth strategy despite potential market uncertainties [3]. - The company continues to focus on enhancing brand value, optimizing operational quality, and innovating product development [3].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 6.87, representing a potential upside of 35.2% from the current price of HKD 5.08 [2][3]. Core Insights - The company experienced a decline in performance due to pressures in the pharmaceutical environment and proactive inventory reduction, with adjusted net profit down 15.2% year-on-year for the first three quarters of 2024 [2]. - Revenue for the first three quarters of 2024 was HKD 22.69 billion, a decrease of 4.9% year-on-year, while gross profit was HKD 15.99 billion, with a gross margin of 70.5%, slightly up by 0.1 percentage points [2]. - The report highlights a shift in the product pipeline, with older products facing revenue declines due to centralized procurement impacts, while new products are expected to drive future growth [2]. Financial Summary - For the first three quarters of 2024, the company reported a net profit of HKD 3.88 billion, down 15.9% year-on-year, with a net profit margin of 17.6%, a decrease of 2.2 percentage points [2]. - The revenue breakdown shows that the prescription drug segment generated HKD 18.67 billion, down 3.5%, while the functional food segment saw a significant decline of 21.9% to HKD 1.29 billion [2]. - Research and development expenses increased by 5.5% year-on-year to HKD 3.88 billion, representing 20.8% of the prescription drug revenue, up 1.8 percentage points [2]. Segment Performance - The report details various segments: - The neurology segment saw a revenue increase of 4.5% to HKD 7.23 billion, but experienced a significant drop of 15.8% in Q3 due to strict cost control measures [2]. - The oncology segment's revenue decreased by 31.2% in Q3, influenced by centralized procurement in the Beijing-Tianjin-Hebei region [2]. - The cardiovascular segment reported a decline of 11.1% to HKD 1.63 billion, with a notable drop of 26.7% in Q3 due to a lack of procurement success [2]. Pipeline and Future Outlook - The company is expected to rely on new product launches to drive growth, with anticipated contributions of approximately HKD 2 billion from innovative products in the coming year [2]. - The report mentions a significant licensing deal with AstraZeneca for a lipoprotein(a) inhibitor, which includes an upfront payment of USD 100 million and potential milestone payments of USD 1.92 billion [2].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 5.6 for the fiscal year 2024/25, based on a 16x PE ratio [1][4]. Core Insights - The company reported a revenue increase of 17.8% year-on-year for FY25H1, reaching RMB 8.804 billion, and a net profit increase of 23% to RMB 1.13 billion, outperforming expectations [2][3]. - The brand's down jacket business saw a revenue growth of 22.7% to RMB 6.06 billion, with a slight decline in gross margin [2]. - The main brand, Bosideng, achieved a revenue of RMB 5.28 billion, up 19.4%, driven by strong sales of new product categories [2][3]. - The OEM business grew by 13.4% to RMB 2.32 billion, while the women's wear segment faced a decline of 21.5% to RMB 308 million due to ongoing industry challenges [2][3]. - The company is focusing on channel optimization and operational efficiency, with a reduction in the number of down jacket stores but an increase in self-operated stores [2][3]. Financial Summary - For the fiscal years 2022/23 to 2026/27, the company is projected to see significant revenue growth, with expected revenues of RMB 26.648 billion in 2024/25, growing to RMB 33.492 billion by 2026/27 [3][8]. - The net profit is expected to rise from RMB 3.601 billion in 2024/25 to RMB 4.524 billion in 2026/27, reflecting a strong growth trajectory [3][8]. - The gross margin is projected to remain stable around 59% over the next few years, indicating consistent profitability [3][11].

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The management team has undergone a significant change, with the appointment of Huang Shaomei as the CEO, who has over 20 years of experience in the real estate sector. This leadership change is expected to enhance the company's operational capabilities in both Hong Kong and mainland China [2][6] - The company has maintained its profit forecasts, expecting net profits for FY2025-2027 to be HKD 370 million, HKD 600 million, and HKD 860 million respectively, with corresponding EPS of HKD 0.15, HKD 0.24, and HKD 0.34. The current stock price corresponds to P/E ratios of 44.7, 27.9, and 19.3 times [2][6] - The company reported a revenue of HKD 35.826 billion for FY2024, a decrease of 62% year-on-year, and a core operating profit of HKD 6.898 billion, down 18% year-on-year. The net profit for continuing operations was negative HKD 11.807 billion due to non-cash impairments and losses [2][6] Financial Summary - For FY2023, the company achieved a revenue of HKD 95.214 billion, with a year-on-year growth of 39.6%. However, for FY2024, the revenue is projected to drop to HKD 35.782 billion, reflecting a significant decline of 62.4% [8] - The net profit for FY2023 was HKD 4.081 billion, but it is expected to turn negative in FY2024 at HKD -17.126 billion, indicating a drastic year-on-year decline of 519.7% [8] - The gross margin for FY2024 is projected to be 35.9%, while the net margin is expected to be -55.1% [8] - The company’s total assets are projected to decrease from HKD 616.483 billion in FY2023 to HKD 445.158 billion in FY2024 [8]

Investment Rating - The investment rating for Meituan-W (03690.HK) is "Outperform the Market" [1][27]. Core Views - The adjusted performance in Q3 continues to show strong growth, with new businesses accelerating their loss reduction. In Q3 2024, the company achieved revenue of 93.58 billion RMB (+22.4%), net profit of 12.83 billion RMB (+258.0%), and adjusted net profit of 12.83 billion RMB (+124.0%), all exceeding Bloomberg consensus estimates [1][7]. - Core local business revenue growth accelerated, with operating profit margin improving year-on-year. In Q3, core local business revenue reached 69.37 billion RMB (+20.2%), with operating profit of 14.58 billion RMB (+44.4%) and an operating profit margin of 21.0% (+3.5 percentage points) [1][9]. - New business revenue in Q3 was 24.2 billion RMB (+28.9%), with operating losses significantly narrowing to 1.03 billion RMB, down from 5.11 billion RMB in the previous year [1][12]. Summary by Relevant Sections Financial Performance - Q3 2024 revenue was 93.58 billion RMB, a 22.4% increase year-on-year, with net profit at 12.83 billion RMB, reflecting a 258.0% increase. Adjusted net profit also reached 12.83 billion RMB, up 124.0% [1][7]. - Core local business revenue grew to 69.37 billion RMB, with delivery, commission, and online marketing revenues increasing by 20.9%, 24.3%, and 18.1% respectively [1][9]. - The operating profit margin improved to 21.0%, although it slightly decreased from Q2 due to seasonal factors [1][9]. New Business Development - New business revenue reached 24.2 billion RMB, with a significant reduction in operating losses to 1.03 billion RMB, down from 5.11 billion RMB in the previous year [1][12]. - The company estimates that the new business, including Meituan Preferred, reduced losses to around 1.7 billion RMB in Q3, with other new businesses contributing a profit of 600-700 million RMB [1][12]. Market Outlook - The company is focusing on expanding its instant retail segment, which is expected to account for over 10% of e-commerce market share by 2027, with projected GTV exceeding 200 billion RMB [1][15]. - Meituan is accelerating its overseas expansion, with Keeta entering Riyadh, Saudi Arabia, in October, which may increase short-term investments but is expected to open new market opportunities in the long term [1][15].

Investment Rating - The report assigns an "Accumulate" rating for the company, with a target price of 217.14 HKD for 2025, based on a 22x PE ratio [4][5][115]. Core Insights - The company is a leading high-end gold jewelry brand in China, focusing on the promotion of "Ancient Method Gold" and has established a differentiated high-end positioning that serves as a foundation for its success. The company has experienced rapid growth, with a CAGR of 58.6% in revenue and 91.2% in net profit from 2021 to 2023 [1][29]. - The market for Ancient Method Gold jewelry is expected to grow significantly, with a projected CAGR of 21.8% from 2023 to 2028, outpacing traditional gold jewelry segments. The company is well-positioned to capitalize on this growth through its comprehensive competitive advantages across branding, product innovation, channel marketing, and strategic development [1][53]. Company Overview - Founded in 2009, the company is recognized as the first brand in China to promote the concept of "Ancient Method Gold" and is the leading brand in the field of traditional handcrafted gold jewelry [1][23]. - The founder has extensive experience in commercializing cultural products, and the management team is stable and experienced [1][41]. Market Potential - The gold jewelry market in China is projected to reach 811 billion RMB by 2028, with a CAGR of 9.4% from 2023 to 2028. The pure gold segment is expected to dominate, with a projected CAGR of 9.7% during the same period [46][47]. - The Ancient Method Gold jewelry market is anticipated to grow from 157.3 billion RMB in 2023 to 421.4 billion RMB by 2028, capturing an increasing market share [53][54]. Brand Positioning - The company fills a gap in the high-end gold jewelry market in China, recognized by high-net-worth individuals. It differentiates itself through a pricing model based on piece pricing rather than weight, which is common among traditional brands [2][62]. - The company has been recognized as one of the top ten jewelry brands favored by high-net-worth individuals in China, indicating strong brand recognition and market acceptance [62][68]. Distribution Channels - The company focuses on high-end shopping centers, achieving significant results with a coverage rate of 80% in major high-end shopping centers in China. The revenue share from five major shopping centers increased from 35.7% in 2021 to 39.1% in 2023 [2][80]. - The company plans to open 15 new stores over the next three years, indicating substantial growth potential in its distribution network [2][90]. Product Competitiveness - The company maintains a strong product development capability, with a focus on strict quality control to ensure high-end positioning. It has a unique advantage in the Ancient Method Gold market, being the only brand dedicated to this segment [3][95]. - The company has a robust pipeline of innovative products, having launched numerous new and updated products in recent years, which enhances its competitive edge [99][100]. Financial Projections - The company forecasts significant growth in earnings per share, projecting 6.93, 9.19, and 11.71 RMB for 2024, 2025, and 2026, respectively. Revenue is expected to grow substantially, driven by both offline and online sales channels [4][110][112].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a decrease in revenue and net profit for the first half of FY2025, with total revenue at HKD 35.734 billion, down 2.70% year-on-year, and net profit at HKD 1.761 billion, down 3.81% year-on-year. The company aims to maintain a dividend of HKD 0.5 per share for the full year, corresponding to a dividend yield of 8.0% [2] - Retail gas volume growth was below expectations, but segment profits showed steady growth. The company adjusted its retail gas volume growth target for the year from +5% to +2% due to lower-than-expected sales [2] - The company is experiencing a gradual price adjustment in its city gas projects, with a price difference increase of 0.29 RMB per cubic meter, and 62% of residential gas volume has achieved price alignment [2] Summary by Sections Financial Performance - For FY2023A, total revenue was HKD 92.423 billion, with a year-on-year growth of 4.31%. For FY2024A, revenue is projected to decrease to HKD 81.863 billion, a decline of 11.43%. The net profit for FY2023A was HKD 4.293 billion, down 43.96% year-on-year, while FY2024A is expected to further decline to HKD 3.185 billion, a decrease of 25.82% [1][2] - The earnings per share (EPS) for FY2023A was HKD 0.79, projected to decrease to HKD 0.59 for FY2024A, with a price-to-earnings (P/E) ratio of 7.89 for FY2023A and 10.64 for FY2024A [1][2] Segment Performance - The natural gas sales segment saw a profit increase of 6.28% to HKD 1.658 billion, while the connection business segment's profit rose by 13.45% to HKD 0.521 billion. The engineering design and construction segment experienced a significant profit increase of 36.25% to HKD 0.349 billion [2] - The LPG sales segment's profit plummeted by 98.96% to HKD 0.02 billion due to various market factors, while the value-added services segment's profit increased by 15.37% to HKD 1.002 billion [2] Future Outlook - The company has revised its net profit forecasts for FY2025 to HKD 3.955 billion, down from the previous estimate of HKD 4.017 billion, with expected growth rates of 24%, 12%, and 10% for FY2025, FY2026, and FY2027 respectively [2] - The P/E ratios for FY2025, FY2026, and FY2027 are projected to be 8.56, 7.64, and 6.96 respectively [2]

Investment Rating - The investment rating for the company is "Buy" [3][8]. Core Insights - In November 2024, the company delivered 48,740 vehicles, representing a year-on-year growth of 18.8%. The projected revenue for 2024-2026 is expected to be 147.3 billion, 205.4 billion, and 280 billion yuan, with year-on-year growth rates of 19.0%, 39.4%, and 36.3% respectively. The net profit attributable to the parent company is forecasted to be 8.53 billion, 14.24 billion, and 23.72 billion yuan, with growth rates of -27.1%, 67.0%, and 66.6% respectively. The EPS is projected to be 4.02, 6.71, and 11.18 yuan per share, with a 3-year CAGR of 40.6% [3][12]. Summary by Sections Delivery Performance - The company achieved a delivery of 48,740 vehicles in November 2024, marking an 18.8% increase year-on-year. Cumulatively, 442,000 vehicles have been delivered as of November 30, 2024. The company has maintained its position as the leading Chinese brand in the 200,000 yuan and above new energy vehicle segment for eight consecutive months [3][12]. Product and Technology Development - The company has accelerated its software capabilities with the AD Max version, which has been rolled out to all users of the AD Max platform. The penetration rate of the end-to-end + VLM system in tested cities has exceeded 50%. The demand for AD Max models has increased significantly, with over 70% of sales in models priced above 300,000 yuan and over 80% in models priced above 400,000 yuan [3][12]. Ecosystem and Infrastructure - As of November 30, 2024, the company has established 475 retail centers across 141 cities and 451 after-sales service centers covering 223 cities. The company has also deployed 1,135 charging stations and 5,680 charging piles nationwide, enhancing its ecosystem [3][12]. Financial Projections - The company forecasts revenues of 147.3 billion, 205.4 billion, and 280 billion yuan for 2024, 2025, and 2026 respectively, with corresponding net profits of 8.53 billion, 14.24 billion, and 23.72 billion yuan. The EPS is expected to grow to 4.02, 6.71, and 11.18 yuan per share over the same period [3][12].

Investment Rating - Maintains a "Buy" rating for XPeng Motors-W (09868) [3][8] Core Views - XPeng Motors delivered 30,895 vehicles in November 2024, a 54% YoY and 29% MoM increase [3][12] - Expected sales for 2024/2025/2026 are 190,000/420,000/640,000 vehicles, with revenues of 434.0/922.9/1382.8 billion yuan, respectively [3][12] - Net profit forecasts for 2024/2025/2026 are -6.51/0.70/3.42 billion yuan, indicating a potential financial turnaround [3][12] - The MONA M03 model has been a hit, with over 10,000 units delivered monthly for three consecutive months, while the P7+ model delivered over 7,000 units in 23 days [12] - XPeng's XNGP urban autonomous driving system achieved an 85% monthly active user penetration rate in November 2024 [12] - The company is expanding globally, entering markets in Nepal and the UK, with further plans for Europe, ASEAN, and other regions [12] Financial Data and Valuation - Total shares outstanding: 1,899 million, with a market cap of 92,679.87 million HKD [8] - Net asset value per share: 20.51 yuan, with a debt-to-asset ratio of 56.04% [8] - Revenue growth rates for 2024/2025/2026 are projected at 41.5%/112.6%/49.8%, respectively [3][12] - EBITDA for 2024/2025/2026 is forecasted at -2,472.59/5,695.07/9,206.22 million yuan [13] - EPS for 2024/2025/2026 is expected to be -3.43/0.37/1.80 yuan per share [13] Industry and Market Performance - XPeng Motors operates in the automotive/passenger vehicle sector [8] - The stock price has shown significant volatility, with a 52-week high/low of 65.50/25.50 HKD [8] - Relative performance compared to the Hang Seng Index shows XPeng outperforming in recent months [9] Strategic Developments - XPeng's "Park-to-Park" autonomous driving solution successfully completed its first test, showcasing advancements in end-to-end autonomous technology [12] - The company's AI Tianji 5.4.0 system, featuring 248 updates across AI driving, cabin, chassis, and connectivity, is now in public testing [12] - XPeng's global strategy is accelerating, with plans to expand further into Europe, ASEAN, and other key regions [12]